LYNN GAMBLE: Open Payments
NPI 1770742884 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,715 in 168 payments from 17 companies in 2025. Trend: 2023 $2,162 · 2024 $2,418 · 2025 $3,715
Food & beverage: $3,715
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 18 | $591 |
| Vanda Pharmaceuticals Inc. | 25 | $500 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 34 | $450 |
| ABBVIE INC. | 24 | $412 |
| Axsome Therapeutics, Inc. | 7 | $350 |
| Neurocrine BioSciences, Inc. | 16 | $316 |
| Alkermes, Inc. | 13 | $276 |
| Janssen Pharmaceuticals, Inc | 4 | $217 |
| Bausch Health US, LLC | 8 | $148 |
| Supernus Pharmaceuticals, Inc. | 2 | $118 |
Products named: FANAPT, CAPLYTA, AUSTEDO XR, VRAYLAR, Auvelity, INGREZZA, INVEGA SUSTENNA, ARISTADA.
Industry payments across CA — which companies pay providers there.
